.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
Fuji
McKesson
Chubb
Healthtrust
Baxter
Federal Trade Commission
Express Scripts
Harvard Business School

Generated: November 21, 2017

DrugPatentWatch Database Preview

Profile for United States of America Patent: 2014080863

« Back to Dashboard

US Patent Family Members and Approved Drugs

These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

US Patent Number US Expiration Date US Applicant US Tradename Generic Name
► SubscribeJul 27, 2025
Glaxosmithkline
ANORO ELLIPTA
umeclidinium bromide; vilanterol trifenatate
► SubscribeJul 27, 2025
Glaxo Grp England
INCRUSE ELLIPTA
umeclidinium bromide
► SubscribeApr 27, 2025
Glaxosmithkline
ANORO ELLIPTA
umeclidinium bromide; vilanterol trifenatate
► SubscribeApr 27, 2025
Glaxo Grp England
INCRUSE ELLIPTA
umeclidinium bromide
► SubscribeApr 27, 2025
Glaxosmithkline
ANORO ELLIPTA
umeclidinium bromide; vilanterol trifenatate
► SubscribeApr 27, 2025
Glaxo Grp England
INCRUSE ELLIPTA
umeclidinium bromide
► SubscribeDec 18, 2027
Glaxosmithkline
ANORO ELLIPTA
umeclidinium bromide; vilanterol trifenatate
► SubscribeDec 18, 2027
Glaxo Grp England
INCRUSE ELLIPTA
umeclidinium bromide
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
US Department of Justice
QuintilesIMS
McKinsey
US Army
Federal Trade Commission
AstraZeneca
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot